Clinical trial
Clinical Trial to Obtain the Highest Efficacy of Dual Antiplatelet Therapy After Carotid Artery Stenting in High Bleeding Risk Patients
NCT06276374 is registered in ClinicalTrials.gov with Woo-Keun Seo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Trial to Obtain the Highest Efficacy of Dual Antiplatelet Therapy After Carotid Artery Stenting in High Bleeding Risk Patients
- Lead sponsor
- Woo-Keun Seo
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 15, 2024
- Completion date
- December 31, 2030
- Enrollment
- 1,556 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.